CISN - The Promise Of Molecular Diagnostics pg. 2
| You Are Here: Home > Cancer Research > New Horizons In Cancer Treatments > The Promise Of Molecular Diagnostics - pg. 2 |
||
The Promise Of
|
![]() |
| Image courtesy of Health & Human Services.gov news |
| Section Index | |
| What We Know About Cancer | |
| How Cancer is Studied | |
| Drug Development | |
| ● | New Treatments |
| Research Advocacy | |
CISN SummaryMolecular diagnostics are becoming important tools for cancer detection and subtyping. This expansion into pharmacogenomics and therapy decision will have major implications for both industry and patients. New technologies will have to deliver greater sensitivity, faster turnaround, and smaller platforms (testing machines), if they are to become part of disease treatment monitoring as well as diagnostics. If this can be achieved, it will also open the door to move from the dedicated diagnostics laboratory to the physician's office. Molecular diagnostics are particularly applicable to:
You have reached the end of this section. If you wish to test your knowledge of "New Horizons in Cancer Treatment"For more information about our e-Training courses, please read the e-Quiz Introduction. |
1 2 |
Next Page» |
